Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
Kennedy Jr.’s rallying cry is what makes it so sickening. Make America Healthy Again? Like when we had more measles and ...
Feature / In 2020, after losing his bid for reelection to Joe Biden, Donald Trump summoned a mob to the Capitol. Today, as we ...
The number of people signing up for Marketplace coverage has surpassed 24 million, an all-time high, breaking last year’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback